Author:
Friedman Joseph I,Lindenmayer Jean-Pierre,Alcantara Frances,Bowler Stephanie,Parak Mohan,White Leonard,Iskander Adel,Parrella Michael,Adler David N,Tsopelas Nicholas D,Tsai Wei-Yann,Novakovick Vladan,Harvey Philip D,Davis Kenneth L
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference40 articles.
1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Health Disorders (4th edn) Washington DC.
2. Andreasen NC, Flaum M, Arndt S (1992). The comprehensive assessment of symptoms and history (CASH): an instrument for assessing psychopathology and diagnosis. Arch Gen Psychiatry 49: 615–623.
3. Anil Ya∂cio∂lu AE, Kivircik Akdede BB, Turgut TI, Tümüklü M, Yazici MK, Alptekin K, Ertuǧrul A, Jayathilake K, Göǧüş A, Tunca Z, Meltzer HY (2005). A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety. J Clin Psychiatry 66: 63–72.
4. Breier A, Buchanan RW, Kirkpatrick B, Davis OR, Irish D, Summerfelt A, Carpenter Jr WT (1994). Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. Am J Psychiatry 151: 20–26.
5. Chouinard G, Ross-Chouinard A, Annable L, Jones B (1980). The extrapyramidal symptom rating scale. Can J Neurol Sci 7: 233.
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献